These cells express high levels of the ubiquitous proliferation marker Ki67 (Fig. 4A); treatment with hUCBSC lowered the expression of Ki67 indicating EGFR-mediated proliferation of glioma cells is inhibited by hUCBSC treatments. The gene discussed is MKI67; the disease is glioma.